No association between DGKH and bipolar disorder in a Scandinavian case-control sample

Area of Science:

• Genetics
• Psychiatric Disorders
• Molecular Biology

Background:

• Single nucleotide polymorphisms (SNPs) in the diacylglycerol kinase eta (DGKH) gene have been suggested to be associated with bipolar disorder (BD).
• Replication studies are crucial for validating genetic associations in complex diseases.
• Understanding the genetic underpinnings of BD is essential for developing targeted treatments.

Purpose of the Study:

• To investigate the potential association between DGKH gene variations and bipolar disorder (BD).
• To replicate previous findings suggesting a link between DGKH SNPs and BD.
• To assess the role of DGKH genetic variations in BD susceptibility within Scandinavian populations.

Main Methods:

• Gene-wide genotyping of 36 tag single nucleotide polymorphisms (SNPs) in the DGKH gene.
• Population-based association study conducted on two independent Scandinavian samples.
• Genotyping successfully performed on 594 individuals with BD and 1421 healthy controls.

Main Results:

• No statistically significant association was found between any of the studied DGKH SNPs and bipolar disorder (BD) after multiple-testing correction.
• The results did not support the hypothesis that the investigated genetic variations in DGKH confer susceptibility to BD.
• The large sample size strengthens the confidence in the negative findings.

Conclusions:

• The investigated single nucleotide polymorphisms (SNPs) in the diacylglycerol kinase eta (DGKH) gene are unlikely to be major contributors to bipolar disorder (BD) susceptibility in the studied Scandinavian populations.
• This study failed to replicate previous findings suggesting a genetic link between DGKH and BD.
• Further research may be needed to explore other genetic factors or environmental influences in the etiology of bipolar disorder.